WO2005007682A3 - A peptide and a pharmaceutical composition, and their medical applications - Google Patents

A peptide and a pharmaceutical composition, and their medical applications Download PDF

Info

Publication number
WO2005007682A3
WO2005007682A3 PCT/PL2004/000057 PL2004000057W WO2005007682A3 WO 2005007682 A3 WO2005007682 A3 WO 2005007682A3 PL 2004000057 W PL2004000057 W PL 2004000057W WO 2005007682 A3 WO2005007682 A3 WO 2005007682A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptide
pharmaceutical composition
medical applications
high affinity
application relates
Prior art date
Application number
PCT/PL2004/000057
Other languages
French (fr)
Other versions
WO2005007682A2 (en
Inventor
Andrzej W Lipkowski
Daniel Carr
Original Assignee
Andrzej W Lipkowski
Daniel Carr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrzej W Lipkowski, Daniel Carr filed Critical Andrzej W Lipkowski
Publication of WO2005007682A2 publication Critical patent/WO2005007682A2/en
Publication of WO2005007682A3 publication Critical patent/WO2005007682A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

The application relates to high affinity opioid receptor ligands which are structually similar to p24 derived peptides.
PCT/PL2004/000057 2003-07-20 2004-07-20 A peptide and a pharmaceutical composition, and their medical applications WO2005007682A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PLP.361364 2003-07-20
PL361364A PL202927B1 (en) 2003-07-20 2003-07-20 Peptide and pharmaceutical composition as well as their therapeutic applications

Publications (2)

Publication Number Publication Date
WO2005007682A2 WO2005007682A2 (en) 2005-01-27
WO2005007682A3 true WO2005007682A3 (en) 2005-08-18

Family

ID=34075208

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2004/000057 WO2005007682A2 (en) 2003-07-20 2004-07-20 A peptide and a pharmaceutical composition, and their medical applications

Country Status (2)

Country Link
PL (1) PL202927B1 (en)
WO (1) WO2005007682A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163263B2 (en) 2012-05-02 2015-10-20 The Goodyear Tire & Rubber Company Identification of isoprene synthase variants with improved properties for the production of isoprene

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8026218B2 (en) 2006-04-26 2011-09-27 The University Of Arizona Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists
FR2903305B1 (en) * 2006-07-07 2012-06-01 Soc Extraction Principes Actif USE OF PLANT EXTRACTS AS SLIMMING ACTIVE INGREDIENTS
KR20100118973A (en) 2007-12-13 2010-11-08 다니스코 유에스 인크. Compositions and methods for producing isoprene
US8173410B2 (en) 2008-04-23 2012-05-08 Danisco Us Inc. Isoprene synthase variants for improved microbial production of isoprene
CA2759700A1 (en) 2009-04-23 2010-10-28 Danisco Us Inc. Three-dimensional structure of isoprene synthase and its use thereof for generating variants
WO2012058494A2 (en) 2010-10-27 2012-05-03 Danisco Us Inc. Isoprene synthase variants for improved production of isoprene
EP3134106A1 (en) 2014-02-24 2017-03-01 The Arizona Board Of Regents On Behalf Of The University Of Arizona Multivalent/multifunctional ligands with agonist activities at opioid receptors and antagonist activities at nk1 receptor for relief of pain

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062368A2 (en) * 2001-02-02 2002-08-15 Mannkind Corporation Method of inducing a ctl response
FR2828934A1 (en) * 2001-08-27 2003-02-28 Inst Nat Sante Rech Med TEST OF CELL IMMUNITY BY FIXED PEPTIDES ON SOLID SUPPORT

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062368A2 (en) * 2001-02-02 2002-08-15 Mannkind Corporation Method of inducing a ctl response
FR2828934A1 (en) * 2001-08-27 2003-02-28 Inst Nat Sante Rech Med TEST OF CELL IMMUNITY BY FIXED PEPTIDES ON SOLID SUPPORT

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DIBRINO M ET AL: "Endogenous peptides with Distinct Amino Acid Anchor Residue Motifs Bind to HLA-A1 and HLA-B8", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 152, no. 2, 1994, pages 620 - 631, XP002080301, ISSN: 0022-1767 *
GAHERY-SEGARD HANNE ET AL: "Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: Characterization of CD8+-T-cell epitopes recognized.", JOURNAL OF VIROLOGY, vol. 77, no. 20, October 2003 (2003-10-01), pages 11220 - 11231, XP002312073, ISSN: 0022-538X *
PETERSON P K ET AL: "Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor", NEUROPHARMACOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 38, no. 2, February 1999 (1999-02-01), pages 273 - 278, XP002236353, ISSN: 0028-3908 *
ZADINA J E ET AL: "A POTENT AND SELECTIVE ENDOGENOUS AGONIST FOR THE MU-OPIATE RECEPTOR", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 386, 3 April 1997 (1997-04-03), pages 499 - 502, XP002072008, ISSN: 0028-0836 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163263B2 (en) 2012-05-02 2015-10-20 The Goodyear Tire & Rubber Company Identification of isoprene synthase variants with improved properties for the production of isoprene

Also Published As

Publication number Publication date
WO2005007682A2 (en) 2005-01-27
PL361364A1 (en) 2005-01-24
PL202927B1 (en) 2009-08-31

Similar Documents

Publication Publication Date Title
EP2949658A3 (en) Peptides that specifically bind HGF receptor (cMet) and uses thereof
WO2004103390A3 (en) Stable analogs of peptide and polypeptide therapeutics
WO2007022239A3 (en) Pharmaceutical formulations for sustained drug delivery
WO2005074970A3 (en) Neuroprotective dietary supplement
WO2005077981A3 (en) Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
WO2006000350A3 (en) Cosmetic compositions containing protein hydrolysates
ATE428727T1 (en) NEW PEPTIDES BINDING TO THE ERYTHROPOIETIN RECEPTOR
EP2279753A3 (en) Remodeling and glycoconjugation of peptides
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2005021022A3 (en) Stable formulations of peptides
WO2006051110A3 (en) Stable formulations of insulinoptropic peptides
IL174479A (en) Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof
WO2007019865A3 (en) Therapy with cd4 binding peptides and radiation
HRP20050024A2 (en) Pegylated t20 polypeptide
WO2006061101A3 (en) Drug delivery peptides for crossing blood-brain barrier
WO2007021572A3 (en) Use of peptides that bind to tpo receptor
WO2006109303A3 (en) Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
CA2530613A1 (en) Rasgap derived peptide for selectively killing cancer cells
WO2003074546A3 (en) Streptavidin-binding peptide
WO2005007682A3 (en) A peptide and a pharmaceutical composition, and their medical applications
WO2008036337A8 (en) Predicted phosphorylation sites
WO2005037236A3 (en) Novel heat shock protein 20-related polypeptides and uses therefor
IL156263A0 (en) Livin-derived peptides, compositions and uses thereof
EP2305311A3 (en) Glycoconjugation of peptides
EP2062915A3 (en) Immunoglobulin fractions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase